Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Vaxcyte, Inc. (PCVX), most recent 12 months reported: net loss $1.06B, free cash flow -$894.14M. Latest balance sheet on file: liquid cash $1.49B. From SEC filings. More on Vaxcyte, Inc.: Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): MAZE THERAPEUTICS, INC. · NEUMORA THERAPEUTICS, INC. · PALISADE BIO, INC. · PASSAGE BIO, INC. · PHARMACYTE BIOTECH, INC. · REPLIMUNE GROUP, INC. · Revolution Medicines, Inc. · SAB BIOTHERAPEUTICS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.